Basit öğe kaydını göster

Long-term follow-up of hepatitis B e antigen-negative patients treated with peginterferon alpha-2a: progressive decrease in hepatitis B surface antigen in responders

dc.contributor.authorBoucher, Charles A.
dc.contributor.authorPinarbasi, Binnur
dc.contributor.authorJanssen, Harry L. A.
dc.contributor.authorvan Vuuren, Anneke J.
dc.contributor.authorHansen, Bettina E.
dc.contributor.authorFerenci, Peter
dc.contributor.authorRijckborst, Vincent
dc.contributor.authorAkdogan, Meral
dc.contributor.authorter Borg, Martijn J.
dc.contributor.authorSimon, Krzysztof
dc.contributor.authorFlisiak, Robert
dc.contributor.authorAKARCA, ULUS SALİH
dc.contributor.authorRaptopoulou-Gigi, Maria
dc.contributor.authorVerhey, Elke
dc.date.accessioned2021-03-03T13:07:07Z
dc.date.available2021-03-03T13:07:07Z
dc.date.issued2012
dc.identifier.citationRijckborst V., Ferenci P., Akdogan M., Pinarbasi B., ter Borg M. J. , Simon K., Flisiak R., AKARCA U. S. , Raptopoulou-Gigi M., Verhey E., et al., "Long-term follow-up of hepatitis B e antigen-negative patients treated with peginterferon alpha-2a: progressive decrease in hepatitis B surface antigen in responders", EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, cilt.24, sa.9, ss.1012-1019, 2012
dc.identifier.issn0954-691X
dc.identifier.othervv_1032021
dc.identifier.otherav_321a4933-6253-4165-bb33-3041cad054f6
dc.identifier.urihttp://hdl.handle.net/20.500.12627/38043
dc.identifier.urihttps://doi.org/10.1097/meg.0b013e3283557e23
dc.description.abstractObjective Peginterferon (PEG-IFN) is considered as a first-line treatment option for hepatitis B e antigen (HBeAg)-negative chronic hepatitis B. We aimed to evaluate the long-term response to PEG-IFN in HBeAg-negative patients.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectİç Hastalıkları
dc.subjectGastroenteroloji-(Hepatoloji)
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectGASTROENTEROLOJİ VE HEPATOLOJİ
dc.titleLong-term follow-up of hepatitis B e antigen-negative patients treated with peginterferon alpha-2a: progressive decrease in hepatitis B surface antigen in responders
dc.typeMakale
dc.relation.journalEUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
dc.contributor.departmentMedical University of Vienna , ,
dc.identifier.volume24
dc.identifier.issue9
dc.identifier.startpage1012
dc.identifier.endpage1019
dc.contributor.firstauthorID206040


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster